Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CERT Certara Inc
- Stocks
- Healthcare
- NASDAQ: CERT
Price (delayed)
$11.64
Market cap
$1.89B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$2.01B
Certara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs
Highlights
The net income has soared by 96% year-on-year and by 78% since the previous quarter
The EPS has soared by 95% YoY and by 75% QoQ
Certara's quick ratio has increased by 31% from the previous quarter but it has decreased by 17% YoY
Key stats
What are the main financial stats of CERT
Market
Valuations
Earnings
Shares outstanding
162.23M
Market cap
$1.89B
Enterprise value
$2.01B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.73
Price to sales (P/S)
4.75
EV/EBIT
150.67
EV/EBITDA
24.09
EV/Sales
5.11
Revenue
$394.5M
Gross profit
$237.72M
Operating income
$7.18M
Net income
-$2.63M
EBIT
$13.37M
EBITDA
$83.59M
Free cash flow
$70.29M
Per share
Balance sheet
Liquidity
EPS
-$0.02
EPS diluted
-$0.02
Free cash flow per share
$0.44
Book value per share
$6.73
Revenue per share
$2.45
TBVPS
$2
Total assets
$1.56B
Total liabilities
$476.73M
Debt
$304.63M
Equity
$1.08B
Working capital
$192.1M
Debt to equity
0.28
Current ratio
2.78
Quick ratio
2.52
Net debt/EBITDA
1.5
Margins
Efficiency
Dividend
EBITDA margin
21.2%
Gross margin
60.3%
Net margin
-0.7%
Operating margin
1.8%
Return on assets
-0.2%
Return on equity
-0.2%
Return on invested capital
4.1%
Return on capital employed
0.9%
Return on sales
3.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CERT stock price
How has the Certara stock price performed over time
Intraday
-1.19%
1 week
-4.12%
1 month
-17.74%
1 year
-28.85%
YTD
9.3%
QTD
17.58%
Financial performance
How have Certara's revenue and profit performed over time
Revenue
$394.5M
Gross profit
$237.72M
Operating income
$7.18M
Net income
-$2.63M
Gross margin
60.3%
Net margin
-0.7%
CERT's operating income has soared by 115% YoY
The operating margin has surged by 113% year-on-year
The net income has soared by 96% year-on-year and by 78% since the previous quarter
CERT's net margin has soared by 96% YoY and by 77% from the previous quarter
Price vs fundamentals
How does CERT's price correlate with its fundamentals
Growth
What is Certara's growth rate over time
Valuation
What is Certara stock price valuation
P/E
N/A
P/B
1.73
P/S
4.75
EV/EBIT
150.67
EV/EBITDA
24.09
EV/Sales
5.11
The EPS has soared by 95% YoY and by 75% QoQ
CERT's price to book (P/B) is 45% lower than its 5-year quarterly average of 3.2 and 2.8% lower than its last 4 quarters average of 1.8
The equity has grown by 2.8% YoY and by 2.4% from the previous quarter
The P/S is 52% below the 5-year quarterly average of 10.0
CERT's revenue is up by 9% YoY and by 2.4% from the previous quarter
Efficiency
How efficient is Certara business performance
Certara's ROIC has soared by 193% from the previous quarter and by 133% YoY
The ROS has soared by 131% YoY
The return on equity has surged by 97% year-on-year and by 82% since the previous quarter
Certara's return on assets has surged by 95% YoY and by 75% QoQ
Dividends
What is CERT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CERT.
Financial health
How did Certara financials performed over time
The company's current ratio rose by 31% QoQ but it fell by 15% YoY
Certara's quick ratio has increased by 31% from the previous quarter but it has decreased by 17% YoY
CERT's debt is 72% less than its equity
The equity has grown by 2.8% YoY and by 2.4% from the previous quarter
The debt to equity has declined by 3.4% since the previous quarter and by 3.4% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.